within Pharmacolibrary.Drugs.ATC.J;

model J01EB06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 1.0,
    adminDuration  = 600,
    adminMass      = 2.0,
    adminCount     = 1,
    Vd             = 0.0003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Sulfanilamide is a synthetic sulfonamide antibacterial agent, historically significant as one of the first effective systemic antibiotics. It inhibits bacterial folic acid synthesis by blocking dihydropteroate synthase. Today, sulfanilamide is rarely used clinically due to toxicity and the availability of safer alternatives. Its modern use is mainly limited to topical formulations.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for a healthy adult population based on available older sources and pharmacological class properties. No directly referenced clinical publication with full PK parameters is available for sulfanilamide.</p><h4>References</h4><ol><li>Anabel Brandoni, Adriana Mónica Torres,Pharmacokinetics of the antimicrobial drug Sulfanilamide is altered in a preclinical model of vascular calcification.,Clinical and experimental pharmacology & physiology,2017<a href='https://pubmed.ncbi.nlm.nih.gov/28042884/'>https://pubmed.ncbi.nlm.nih.gov/28042884/</a></li><li>Radojka M Savic, Daniël M Jonker, Thomas Kerbusch, Mats O Karlsson,Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies.,Journal of pharmacokinetics and pharmacodynamics,2007<a href='https://pubmed.ncbi.nlm.nih.gov/17653836/'>https://pubmed.ncbi.nlm.nih.gov/17653836/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01EB06;
